ADAGIO THERAPEUTICS
Adagio is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company’s portfolio of antibodies has been optimized using Adimab’s industry-leading antibody engineering capabilities and is designed to provide patients and clinicians with a powerful combination of potency, breadth, durable protection (via half-life extension), manufacturability and affordability. ... Adagio’s portfolio of SARS-CoV-2 antibodies includes multiple, non-competing broadly neutralizing antibodies with distinct binding epitopes, led by ADG20. Adagio has secured manufacturing capacity for the production of ADG20 with thirdparty contract manufacturers through the completion of clinical trials and, if approved by regulatory authorities, through initial commercial launch.
ADAGIO THERAPEUTICS
Industry:
Biotechnology Pharmaceutical Therapeutics
Founded:
2020-01-01
Address:
Waltham, Massachusetts, United States
Country:
United States
Website Url:
http://www.adagiotx.com
Total Employee:
51+
Status:
Active
Contact:
781-819-0080
Total Funding:
466 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Apple Mobile Web Clips Icon WordPress Wordpress Plugins Mobile Non Scaleable Content Microsoft Exchange Online
Similar Organizations
Click Therapeutics
Click Therapeutics delivers safe and effective digital treatments to patients in need.
Spero Therapeutics
Spero Therapeutics is developing first in class therapeutics for treatment of gram-negative infections.
Current Advisors List
Board_member
2020-07-01
Board_member
2020-07-01
Board_member
2020-07-01
Board_member
2020-07-01
Current Employees Featured
Tillman Gerngross Co-Founder and CEO @ Adagio Therapeutics
Co-Founder and CEO
Eric Kimble CCO @ Adagio Therapeutics
CCO
Ellie Hershberger CDO @ Adagio Therapeutics
CDO
Lynn Connolly CMO @ Adagio Therapeutics
CMO
Lawrence Beck Vice President of Finance @ Adagio Therapeutics
Vice President of Finance
HALLEY GILBERT COO & CBO @ Adagio Therapeutics
COO & CBO
Michele Crosby Head of Legal & HR Operations @ Adagio Therapeutics
Head of Legal & HR Operations
Rebecca Dabora Chief Technology & Manufacturing Officer @ Adagio Therapeutics
Chief Technology & Manufacturing Officer
David Hering CEO @ Adagio Therapeutics
CEO
2021-07-01
Jane Pritchett Henderson Chief Financial Officer @ Adagio Therapeutics
Chief Financial Officer
2020-12-01
Founder
Stock Details
Investors List
OrbiMed
OrbiMed investment in Series C - Adagio Therapeutics
Population Health Partners
Population Health Partners investment in Series C - Adagio Therapeutics
Adimab
Adimab investment in Series C - Adagio Therapeutics
Mithril Capital Management
Mithril Capital Management investment in Series C - Adagio Therapeutics
GV
GV investment in Series C - Adagio Therapeutics
Fidelity Management and Research Company
Fidelity Management and Research Company investment in Series C - Adagio Therapeutics
Redmile Group
Redmile Group investment in Series C - Adagio Therapeutics
Foresite Capital
Foresite Capital investment in Series C - Adagio Therapeutics
Polaris Partners
Polaris Partners investment in Series C - Adagio Therapeutics
ArrowMark Partners
ArrowMark Partners investment in Series C - Adagio Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2021-07-19 | Adagio Therapeutics Appoints David Hering, Global COVID-19 Vaccine Expert, as Chief Operating Officer |
Official Site Inspections
http://www.adagiotx.com Semrush global rank: 3.47 M Semrush visits lastest month: 4.37 K
- Host name: f3.68.7e4b.ip4.static.sl-reverse.com
- IP address: 75.126.104.243
- Location: Dallas United States
- Latitude: 32.9379
- Longitude: -96.8384
- Metro Code: 623
- Timezone: America/Chicago
- Postal: 75244
